Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The genomic landscape of metastasis in treatment-naïve breast cancer models

ABSTRACT: The genomic landscape of metastasis in treatment-naïve breast cancer models

PROVIDER: PRJNA596799 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10742100_1.fastq.gz	Fastqsanger.gz
	SRR10742100_2.fastq.gz	Fastqsanger.gz
	SRR10742101_1.fastq.gz	Fastqsanger.gz
	SRR10742101_2.fastq.gz	Fastqsanger.gz
	SRR10742102_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 398

Similar Datasets

The genomic landscape of metastasis in treatment-naïve breast cancer models

Project description:Exome and whole genome sequencing of matched primary tumor and lung metastases was used to identify metastasis-specific genomic events that drive metastasis.

2020-04-02 | GSE142387 | GEO

Project description:Immune system plays a dual role in cancer by either targeting or supporting neoplastic cells at various stages of disease, including metastasis. Yet, the exact immune-related transcriptome profiles of breast cancer cells and their evolution during dissemination remain undiscovered. This study aimed at exploring immune-related transcriptomic landscape of primary tumors and lymph node metastasis of chemotherapy-naïve breast cancer patients.

2021-07-21 | GSE180186 | GEO

Transcriptomic Landscape of Treatment - Naïve Erosive Esophagitis

Project description:Transcriptomic Landscape of Treatment - Naïve Erosive Esophagitis

| PRJNA785600 | ENA

The genomic landscape of metastasis in treatment-naive breast cancer models.

Project description:Metastasis remains the principle cause of mortality for breast cancer and presents a critical challenge because secondary lesions are often refractory to conventional treatments. While specific genetic alterations are tightly linked to primary tumor development and progression, the role of genetic alteration in the metastatic process is not well-understood. The theory of tumor evolution postulated by Peter Nowell in 1976 has yet to be proven in the context of metastasis. Therefore, in order to investigate how somatic evolution contributes to breast cancer metastasis, we performed exome, whole genome, and RNA sequencing of matched metastatic and primary tumors from pre-clinical mouse models of breast cancer. Here we show that in a treatment-naïve setting, recurrent single nucleotide variants and copy number variation, but not gene fusion events, play key metastasis-driving roles in breast cancer. For instance, we identified recurrent mutations in Kras, a known driver of colorectal and lung tumorigenesis that has not been previously implicated in breast cancer metastasis. However, in a set of in vivo proof-of-concept experiments we show that the Kras G12D mutation is sufficient to significantly promote metastasis using three syngeneic allograft models. The work herein confirms the existence of metastasis-driving mutations and presents a novel framework to identify actionable metastasis-targeted therapies.

| S-EPMC7282675 | biostudies-literature

Transcriptomic Landscape of Treatment - Naïve Non-Erosive Reflux Disease

Project description:Transcriptomic Landscape of Treatment - Naïve Non-Erosive Reflux Disease

| PRJNA758571 | ENA

Project description:Immune-related transcriptomic landscape of primary tumors and lymph node metastasis of chemotherapy-naïve breast cancer patients

| PRJNA746991 | ENA

The translational landscape of naïve and primed state pluripotency

Project description:Translational control plays a central role in regulation of gene expression and can lead to significant divergence between mRNA- and protein-abundance. The translational landscape of early mammalian development and its impact on cellular proteome, however, remains largely un-explored. Here we used genome-wide approaches combined with time-course analysis to measure the mRNA-abundance, mRNA-translation rate and protein expression during the transition of naïve into primed embryonic stem cells (ESCs). We found that the ground state ESCs cultured with GSK3- and MEK-inhibitors and LIF (2iL) display higher ribosome density on a selective set of mRNAs. These mRNAs show reduced translation during the exit from ground state pluripotency and transition to serum/LIF (SL) culture or upon commitment to primed epiblast-like stem cells (EpiLSCs). Strikingly, integrative analysis with cellular proteome indicate a strong translational buffering of this set of mRNAs in 2iL-ESCs leading to stable protein expression levels. Our data reveal that the global alteration of cellular proteome is largely accompanied by transcriptional rewiring. Furthermore, we identified a set of genes (including UHRF1 and KRAS) that undergo selective post-translational regulation during the transition of naïve into primed pluripotency and linked the observed changes to upstream GSK- and MEK/MAPK-signaling pathways using single inhibitor treated ESCs. Thus, we provide a comprehensive and detailed overview of the global changes in gene expression during the transition of naïve to primed pluripotency and dissect the relative contributions of RNA-transcription, translation and regulation of protein stability in controlling protein abundance.

2020-04-03 | PXD014528 | Pride

Immunocompetent models of brain parenchymal and leptomeningeal metastasis

Project description:Immunocompetent models of brain parenchymal and leptomeningeal metastasis

| PRJNA913954 | ENA

Analysis of the brain metastasis-associated microenvironment in different preclinical models of brain metastasis

Project description:Analysis of the brain metastasis-associated microenvironment in different preclinical models of brain metastasis

| PRJNA967234 | ENA

Transcriptional and chromatin landscape profiles of naïve CD4 T cells

Project description:Transcriptional and chromatin landscape profiles of naïve CD4 T cells

| PRJNA770364 | ENA